Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2023-08-24

SEC-registered investment adviser since 2010 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 25
Greenwich, CTUnited States United States1
Miami Beach, FLUnited States United States1
Sheridan, WYUnited States United States1
Water Mill, NYUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.4bn reported value +1.8% vs Q1 2023
88positions
43.7%in top 10
12 new 21 added 30 reduced 22 sold out vs Q1 2023

Options: 3 call positions ($1.4m notional), 4 put positions ($11.6m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMICUS THERAPEUTICS INC COM FOLD FOLD 27,662,917 $347.4m10.09% 10.09% UnchangedShares held: Q3 2022 27.4m, Q4 2022 27.6m, Q1 2023 27.7m, Q2 2023 27.7m
2 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 10,088,385 $320.7m9.32% 9.32% AddedShares held: Q3 2022 6.5m, Q4 2022 6.5m, Q1 2023 6.5m, Q2 2023 10.1m +3.6m +3,576,658 54.9%
3 LIANBIO SPONSORED ADS LIANY LIANY 57,558,451 $131.2m3.81% 3.81% UnchangedShares held: Q3 2022 57.6m, Q4 2022 57.6m, Q1 2023 57.6m, Q2 2023 57.6m
4 ARCELLX INC COMMON STOCK ACLX ACLX 4,016,397 $127.0m3.69% 3.69% AddedShares held: Q3 2022 2.5m, Q4 2022 2.6m, Q1 2023 3.8m, Q2 2023 4.0m +174.7k +174,658 4.5%
5 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 4,873,919 $105.1m3.05% 3.05% ReducedShares held: Q3 2022 5.5m, Q4 2022 6.1m, Q1 2023 6.0m, Q2 2023 4.9m -1.2m -1,160,725 -19.2%
6 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 14,036,410 $98.8m2.87% 2.87% ReducedShares held: Q3 2022 10.2m, Q4 2022 10.0m, Q1 2023 15.3m, Q2 2023 14.0m -1.3m -1,303,325 -8.5%
7 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 11,350,085 $95.2m2.77% 2.77% UnchangedShares held: Q3 2022 11.4m, Q4 2022 11.4m, Q1 2023 11.4m, Q2 2023 11.4m
8 INHIBRX INC COM INBX INBX 3,624,182 $94.1m2.73% 2.73% AddedShares held: Q3 2022 2.9m, Q4 2022 3.3m, Q1 2023 3.6m, Q2 2023 3.6m +8.8k +8,799 0.2%
9 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 4,397,116 $93.0m2.70% 2.70% AddedShares held: Q3 2022 5.0m, Q4 2022 4.9m, Q1 2023 2.7m, Q2 2023 4.4m +1.7m +1,663,326 60.8%
10 NUVALENT INC COM COM 2,194,821 $92.6m2.69% 2.69% ReducedShares held: Q3 2022 1.7m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.2m -105.2k -105,227 -4.6%
11 AKERO THERAPEUTICS INC COM AKRO AKRO 1,940,675 $90.6m2.63% 2.63% AddedShares held: Q3 2022 430.0k, Q4 2022 350.5k, Q1 2023 523.5k, Q2 2023 1.9m +1.4m +1,417,150 270.7%
12 VAXCYTE INC COM PCVX PCVX 1,614,122 $80.6m2.34% 2.34% AddedShares held: Q3 2022 0, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.6m +444.1k +444,122 38.0%
13 MEIRAGTX HLDGS PLC COM MGTX MGTX 11,331,103 $76.1m2.21% 2.21% AddedShares held: Q3 2022 7.0m, Q4 2022 7.0m, Q1 2023 7.0m, Q2 2023 11.3m +4.4m +4,367,826 62.7%
14 APELLIS PHARMACEUTICALS INC COM APLS APLS 812,037 $74.0m2.15% 2.15% AddedShares held: Q3 2022 366.4k, Q4 2022 0, Q1 2023 555.3k, Q2 2023 812.0k +256.7k +256,693 46.2%
15 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 302,987 $70.0m2.03% 2.03% ReducedShares held: Q3 2022 331.0k, Q4 2022 731.9k, Q1 2023 650.6k, Q2 2023 303.0k -347.6k -347,575 -53.4%
16 REATA PHARMACEUTICALS INC CL A RETA RETA 670,206 $68.3m1.99% 1.99% ReducedShares held: Q3 2022 100.0k, Q4 2022 0, Q1 2023 2.2m, Q2 2023 670.2k -1.5m -1,499,070 -69.1%
17 TREACE MED CONCEPTS INC COM TMCI TMCI 2,217,250 $56.7m1.65% 1.65% ReducedShares held: Q3 2022 1.6m, Q4 2022 1.9m, Q1 2023 2.4m, Q2 2023 2.2m -225.0k -225,000 -9.2%
18 LYRA THERAPEUTICS INC COM LYRA LYRA 12,757,562 $52.4m1.52% 1.52% AddedShares held: Q3 2022 9.1m, Q4 2022 9.1m, Q1 2023 9.1m, Q2 2023 12.8m +3.6m +3,610,832 39.5%
19 VIR BIOTECHNOLOGY INC COM VIR VIR 1,958,264 $48.0m1.40% 1.40% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 142.2k, Q2 2023 2.0m +1.8m +1,816,070 1277.2%
20 IMMUNOVANT INC COM IMVT IMVT 2,523,783 $47.9m1.39% 1.39% AddedShares held: Q3 2022 0, Q4 2022 150.0k, Q1 2023 1.3m, Q2 2023 2.5m +1.2m +1,231,925 95.4%
21 XENON PHARMACEUTICALS INC COM XENE XENE 1,223,377 $47.1m1.37% 1.37% ReducedShares held: Q3 2022 2.1m, Q4 2022 1.9m, Q1 2023 1.8m, Q2 2023 1.2m -608.8k -608,797 -33.2%
22 ADMA BIOLOGICS INC COM ADMA ADMA 11,900,255 $43.9m1.28% 1.28% UnchangedShares held: Q3 2022 10.9m, Q4 2022 11.9m, Q1 2023 11.9m, Q2 2023 11.9m
23 RAPT THERAPEUTICS INC COM COM 2,288,493 $42.8m1.24% 1.24% ReducedShares held: Q3 2022 1.7m, Q4 2022 1.8m, Q1 2023 2.3m, Q2 2023 2.3m -3.1k -3,115 -0.1%
24 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,776,386 $42.3m1.23% 1.23% AddedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.7m, Q2 2023 1.8m +40.0k +40,000 2.3%
25 MEDTRONIC PLC SHS MDT MDT 467,000 $41.1m1.20% 1.20% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 467.0k
26 CYMABAY THERAPEUTICS INC COM CBAY CBAY 3,733,255 $40.9m1.19% 1.19% ReducedShares held: Q3 2022 0, Q4 2022 709.0k, Q1 2023 3.9m, Q2 2023 3.7m -170.0k -170,000 -4.4%
27 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 1,469,761 $40.6m1.18% 1.18% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 965.2k, Q2 2023 1.5m +504.6k +504,609 52.3%
28 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 1,537,431 $40.3m1.17% 1.17% ReducedShares held: Q3 2022 3.5m, Q4 2022 2.6m, Q1 2023 2.1m, Q2 2023 1.5m -541.9k -541,921 -26.1%
29 IMMATICS N.V SHS IMTX IMTX 3,491,500 $40.3m1.17% 1.17% UnchangedShares held: Q3 2022 2.5m, Q4 2022 3.5m, Q1 2023 3.5m, Q2 2023 3.5m
30 ACRIVON THERAPEUTICS INC COMMON STOCK ACRV ACRV 3,007,858 $39.0m1.13% 1.13% UnchangedShares held: Q3 2022 0, Q4 2022 3.0m, Q1 2023 3.0m, Q2 2023 3.0m
31 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 9,111,151 $35.3m1.02% 1.02% UnchangedShares held: Q3 2022 9.1m, Q4 2022 9.1m, Q1 2023 9.1m, Q2 2023 9.1m
32 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,946,937 $35.1m1.02% 1.02% ReducedShares held: Q3 2022 5.3m, Q4 2022 4.0m, Q1 2023 3.6m, Q2 2023 1.9m -1.6m -1,607,950 -45.2%
33 DISC MEDICINE INC COM IRON IRON 742,838 $33.0m0.96% 0.96% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 742.8k
34 ROIVANT SCIENCES LTD SHS ROIV ROIV 3,131,736 $31.6m0.92% 0.92% AddedShares held: Q3 2022 0, Q4 2022 2.0m, Q1 2023 2.7m, Q2 2023 3.1m +439.6k +439,600 16.3%
35 COGENT BIOSCIENCES INC COM COGT COGT 2,659,470 $31.5m0.91% 0.91% AddedShares held: Q3 2022 3.2m, Q4 2022 3.2m, Q1 2023 2.3m, Q2 2023 2.7m +377.1k +377,146 16.5%
36 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 891,370 $31.4m0.91% 0.91% AddedShares held: Q3 2022 411.8k, Q4 2022 411.8k, Q1 2023 100.0k, Q2 2023 891.4k +791.4k +791,370 791.4%
37 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,748,933 $30.1m0.87% 0.87% ReducedShares held: Q3 2022 1.7m, Q4 2022 1.7m, Q1 2023 1.9m, Q2 2023 1.7m -158.1k -158,100 -8.3%
38 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 424,924 $29.2m0.85% 0.85% ReducedShares held: Q3 2022 578.3k, Q4 2022 497.9k, Q1 2023 467.9k, Q2 2023 424.9k -42.9k -42,933 -9.2%
39 VERRICA PHARMACEUTICALS INC COM COM 5,038,983 $29.1m0.84% 0.84% UnchangedShares held: Q3 2022 5.0m, Q4 2022 5.0m, Q1 2023 5.0m, Q2 2023 5.0m
40 ILLUMINA INC COM ILMN ILMN 145,000 $27.2m0.79% 0.79% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 145.0k
41 ARGENX SE SPONSORED ADR ARGX ARGX 69,000 $26.9m0.78% 0.78% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 69.0k
42 MIRATI THERAPEUTICS INC COM MRTX MRTX 719,103 $26.0m0.75% 0.75% ReducedShares held: Q3 2022 2.8m, Q4 2022 2.2m, Q1 2023 1.6m, Q2 2023 719.1k -855.0k -855,031 -54.3%
43 RELAY THERAPEUTICS INC COM RLAY RLAY 1,943,097 $24.4m0.71% 0.71% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 1.9m
44 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,296,416 $23.4m0.68% 0.68% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m
45 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,168,363 $23.2m0.67% 0.67% AddedShares held: Q3 2022 500.0k, Q4 2022 1.1m, Q1 2023 867.7k, Q2 2023 1.2m +300.6k +300,631 34.6%
46 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 263,207 $22.8m0.66% 0.66% ReducedShares held: Q3 2022 336.5k, Q4 2022 506.5k, Q1 2023 673.1k, Q2 2023 263.2k -409.9k -409,853 -60.9%
47 ZYMEWORKS INC COM ZYME ZYME 2,416,232 $20.9m0.61% 0.61% ReducedShares held: Q3 2022 0, Q4 2022 4.5m, Q1 2023 3.4m, Q2 2023 2.4m -962.3k -962,266 -28.5%
48 CABALETTA BIO INC COM CABA CABA 1,545,000 $19.9m0.58% 0.58% AddedShares held: Q3 2022 0, Q4 2022 317.5k, Q1 2023 724.8k, Q2 2023 1.5m +820.2k +820,223 113.2%
49 OUTSET MED INC COM OM OM 902,360 $19.7m0.57% 0.57% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 902.4k -187.1k -187,067 -17.2%
50 NATERA INC COM NTRA NTRA 405,269 $19.7m0.57% 0.57% ReducedShares held: Q3 2022 120.0k, Q4 2022 130.0k, Q1 2023 707.2k, Q2 2023 405.3k -301.9k -301,945 -42.7%
51 AXSOME THERAPEUTICS INC COM AXSM AXSM 271,493 $19.5m0.57% 0.57% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 271.5k
52 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 3,495,933 $18.3m0.53% 0.53% UnchangedShares held: Q3 2022 0, Q4 2022 3.5m, Q1 2023 3.5m, Q2 2023 3.5m
53 ASTRIA THERAPEUTICS INC COM CATB CATB 2,189,462 $18.2m0.53% 0.53% UnchangedShares held: Q3 2022 1.3m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
54 ARTIVION INC COM AORT AORT 931,352 $16.0m0.47% 0.47% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 931.4k -154.5k -154,508 -14.2%
55 BIOMEA FUSION INC COM BMEA BMEA 716,441 $15.7m0.46% 0.46% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 325.0k, Q2 2023 716.4k +391.4k +391,441 120.4%
56 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 245,800 $15.6m0.45% 0.45% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 245.8k
57 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 601,566 $15.6m0.45% 0.45% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 601.6k, Q2 2023 601.6k
58 TACTILE SYS TECHNOLOGY INC COM TCMD TCMD 602,377 $15.0m0.44% 0.44% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 639.9k, Q2 2023 602.4k -37.5k -37,500 -5.9%
59 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 2,052,868 $14.4m0.42% 0.42% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.3m, Q2 2023 2.1m -225.4k -225,358 -9.9%
60 ATHIRA PHARMA INC COM COM 4,797,278 $14.2m0.41% 0.41% UnchangedShares held: Q3 2022 4.8m, Q4 2022 4.8m, Q1 2023 4.8m, Q2 2023 4.8m
61 AXOGEN INC COM AXGN AXGN 1,464,822 $13.4m0.39% 0.39% AddedShares held: Q3 2022 949.6k, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.5m +55.0k +55,031 3.9%
62 FUSION PHARMACEUTICALS INC COM COM 2,751,395 $12.8m0.37% 0.37% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.8m, Q2 2023 2.8m -8.5k -8,541 -0.3%
63 PROTHENA CORP PLC SHS PRTA PRTA 184,615 $12.6m0.37% 0.37% ReducedShares held: Q3 2022 230.0k, Q4 2022 237.6k, Q1 2023 237.6k, Q2 2023 184.6k -53.0k -53,031 -22.3%
64 CAREMAX INC COM CL A COM CL A 3,817,404 $11.9m0.34% 0.34% AddedShares held: Q3 2022 3.4m, Q4 2022 3.1m, Q1 2023 3.6m, Q2 2023 3.8m +241.4k +241,364 6.8%
65 SOLENO THERAPEUTICS INC COM SLNO SLNO 2,207,753 $9.5m0.28% 0.28% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.2m
66 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 100,050 $9.4m0.27% 0.27% UnchangedShares held: Q3 2022 100.0k, Q4 2022 100.0k, Q1 2023 100.0k, Q2 2023 100.0k
67 SAREPTA THERAPEUTICS INC COM SRPT SRPT 81,074 $9.3m0.27% 0.27% ReducedShares held: Q3 2022 253.0k, Q4 2022 649.2k, Q1 2023 260.9k, Q2 2023 81.1k -179.8k -179,784 -68.9%
68 BIOHAVEN LTD COM BHVN BHVN 320,820 $7.7m0.22% 0.22% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 320.8k
69 VIKING THERAPEUTICS INC COM VKTX VKTX 441,147 $7.2m0.21% 0.21% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 871.7k, Q2 2023 441.1k -430.6k -430,600 -49.4%
70 X4 PHARMACEUTICALS INC COM COM 3,545,454 $6.9m0.20% 0.20% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 4.5m, Q2 2023 3.5m -1.0m -1,000,000 -22.0%
71 IVERIC BIO INC COM OPHT OPHT 168,000 $6.6m0.19% 0.19% ReducedShares held: Q3 2022 1.0m, Q4 2022 587.4k, Q1 2023 500.0k, Q2 2023 168.0k -332.0k -332,000 -66.4%
72 LANDOS BIOPHARMA INC COM NEW COM NEW 1,486,991 $6.3m0.18% 0.18% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.5m
73 TYRA BIOSCIENCES INC COM TYRA TYRA 360,000 $6.1m0.18% 0.18% ReducedShares held: Q3 2022 494.4k, Q4 2022 494.4k, Q1 2023 494.4k, Q2 2023 360.0k -134.4k -134,403 -27.2%
74 NANOBIOTIX SPONSORED ADS NBTX NBTX 1,059,800 $5.4m0.16% 0.16% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
75 VBI VACCINES INC CDA COM NEW VAC VAC 1,381,355 $4.5m0.13% 0.13% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.4m
76 ACELYRIN INC COM COM 200,000 $4.2m0.12% 0.12% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 200.0k
77 SOMALOGIC INC CLASS A COM SLGC SLGC 1,500,000 $3.5m0.10% 0.10% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
78 KRONOS BIO INC COM KRON KRON 1,752,745 $3.0m0.09% 0.09% UnchangedShares held: Q3 2022 2.2m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m
79 QUANTERIX CORP COM QTRX QTRX 130,000 $2.9m0.09% 0.09% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 130.0k, Q2 2023 130.0k
80 ENVVENO MEDICAL CORPORATION COM COM 781,615 $2.4m0.07% 0.07% UnchangedShares held: Q3 2022 781.6k, Q4 2022 781.6k, Q1 2023 781.6k, Q2 2023 781.6k
81 SINGULAR GENOMICS SYSTEMS IN COM COM 2,363,214 $2.0m0.06% 0.06% ReducedShares held: Q3 2022 3.5m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 2.4m -919.1k -919,061 -28.0%
82 LEAP THERAPEUTICS INC COM NEW CYPH CYPH 586,733 $1.8m0.05% 0.05% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 586.7k
83 TRAVERE THERAPEUTICS INC COM TVTX TVTX 90,748 $1.4m0.04% 0.04% UnchangedShares held: Q3 2022 90.7k, Q4 2022 90.7k, Q1 2023 90.7k, Q2 2023 90.7k
84 VERU INC COM COM 89,878 $107.0k0.00% 0.00% ReducedShares held: Q3 2022 3.9m, Q4 2022 7.9m, Q1 2023 4.3m, Q2 2023 89.9k -4.2m -4,208,334 -97.9%
85 MOTUS GI HLDGS INC COM NEW COM NEW 90,027 $60.3k0.00% 0.00% UnchangedShares held: Q3 2022 90.0k, Q4 2022 90.0k, Q1 2023 90.0k, Q2 2023 90.0k
86 EQRX INC *W EXP 12/17/202 *W EXP 12/17/202 250,000 $42.5k0.00% 0.00% UnchangedShares held: Q3 2022 250.0k, Q4 2022 250.0k, Q1 2023 250.0k, Q2 2023 250.0k
87 CAREMAX INC *W EXP 06/08/202 *W EXP 06/08/202 60,000 $23.4k0.00% 0.00% UnchangedShares held: Q3 2022 60.0k, Q4 2022 60.0k, Q1 2023 60.0k, Q2 2023 60.0k
88 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 166,666 $10.0k0.00% 0.00% UnchangedShares held: Q3 2022 166.7k, Q4 2022 166.7k, Q1 2023 166.7k, Q2 2023 166.7k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
PROMETHEUS BIOSCIENCES INC 1,272,694 $136.6m1.3m shares
SANOFI SNY SNY 768,101 $41.8m768.1k shares
BELLUS HEALTH INC NEW BLU BLU 4,952,538 $35.7m5.0m shares
TERNS PHARMACEUTICALS INC 1,350,000 $16.0m1.4m shares
VBI VACCINES INC CDA 52,335,002 $15.9m52.3m shares
RAIN ONCOLOGY INC 1,648,215 $14.4m1.6m shares
INTUITIVE SURGICAL INC ISRG ISRG 50,000 $12.8m50.0k shares
CYTEK BIOSCIENCES INC CTKB CTKB 1,289,534 $11.9m1.3m shares
LARIMAR THERAPEUTICS INC LRMR LRMR 2,280,709 $10.3m2.3m shares
MORPHIC HLDG INC MORF MORF 256,737 $9.7m256.7k shares
BELLEROPHON THERAPEUTICS INC BLPH BLPH 930,000 $7.3m930.0k shares
HILLEVAX INC 406,024 $6.7m406.0k shares
AVADEL PHARMACEUTICALS PLC 590,000 $5.4m590.0k shares
LANDOS BIOPHARMA INC 14,869,915 $4.4m14.9m shares
ADC THERAPEUTICS SA ADCT ADCT 1,495,805 $2.9m1.5m shares
PHENOMEX INC BLI BLI 2,506,442 $2.9m2.5m shares
LEAP THERAPEUTICS INC LPTX LPTX 6,726,496 $2.3m6.7m shares
DARIOHEALTH CORP DRIO DRIO 313,869 $1.3m313.9k shares
CLOVER HEALTH INVESTMENTS CO CLOV CLOV 1,500,000 $1.3m1.5m shares
ATHENEX INC 776,623 $1.0m776.6k shares
PROTARA THERAPEUTICS INC TARA TARA 290,051 $907.9k290.1k shares
PEAR THERAPEUTICS INC 900,548 $229.6k900.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TERNS PHARMACEUTICALS INC Put Put 1,075,000 $9.4m1.1m shares New
ARCUTIS BIOTHERAPEUTICS INC ARQT · Put ARQTPut 300,000 $1.4m300.0k shares New
MIRATI THERAPEUTICS INC MRTX · Call MRTXCall 200,000 $690.0k200.0k shares New
VERONA PHARMA PLC VRNA · Call VRNACall 500,000 $675.0k500.0k shares New
POINT BIOPHARMA GLOBAL INC Put Put 500,000 $675.0k500.0k shares New
SPDR SER TR XBI · Put XBIPut 150,000 $137.5k150.0k shares Added
BIOXCEL THERAPEUTICS INC Call Call 439,500 $11.0k439.5k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider in Q2 2023

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2023-05-05 MEIRAGTX HLDGS PLC Director · See Footnote MGTX Bought 4,347,826 $25.0m4.3m shares +63%